Par Drugs (India) Price History

PAR Stock   89.40  2.82  3.06%   
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 89.40, as last reported on the 28th of March, with the highest price reaching 93.99 and the lowest price hitting 88.50 during the day.
200 Day MA
217.8264
50 Day MA
144.9814
Beta
0.124
 
Covid
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of -0.39, which implies the firm had a -0.39 % return per unit of risk over the last 3 months. Par Drugs And exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Par Drugs' Risk Adjusted Performance of (0.32), coefficient of variation of (257.12), and Variance of 10.01 to confirm the risk estimate we provide.
  
The current year's Total Stockholder Equity is expected to grow to about 1 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 11.2 M. . Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3895

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPAR

Estimated Market Risk

 3.28
  actual daily
29
71% of assets are more volatile

Expected Return

 -1.28
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.39
  actual daily
0
Most of other assets perform better
Based on monthly moving average Par Drugs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding Par Drugs to a well-diversified portfolio.
Price Book
1.1727
Book Value
78.685
Enterprise Value
946.9 M
Enterprise Value Ebitda
3.8851
Price Sales
1.0842

Par Drugs Stock Price History Chart

There are several ways to analyze Par Stock price data. The simplest method is using a basic Par candlestick price chart, which shows Par Drugs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 2, 2025217.99
Lowest PriceMarch 27, 202589.4

Par Drugs March 28, 2025 Stock Price Synopsis

Various analyses of Par Drugs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Par Stock. It can be used to describe the percentage change in the price of Par Drugs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Par Stock.
Par Drugs Market Facilitation Index 0.0001 
Par Drugs Accumulation Distribution 2,733 
Par Drugs Price Action Indicator(3.25)
Par Drugs Price Daily Balance Of Power(0.51)
Par Drugs Price Rate Of Daily Change 0.97 

Par Drugs March 28, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Par Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Par Drugs intraday prices and daily technical indicators to check the level of noise trading in Par Stock and then apply it to test your longer-term investment strategies against Par.

Par Stock Price History Data

The price series of Par Drugs for the period between Sat, Dec 28, 2024 and Fri, Mar 28, 2025 has a statistical range of 128.59 with a coefficient of variation of 28.92. The price distribution for the period has arithmetic mean of 158.56. The median price for the last 90 days is 185.41. The company completed stock split (2:1) on 27th of April 2021. Par Drugs And had dividends distributed to its stock-holders on 2021-11-22.
OpenHighLowCloseVolume
03/27/2025 90.50  93.99  88.50  89.40  46,794 
03/26/2025 96.75  96.75  91.51  92.22  38,529 
03/25/2025 97.28  99.50  93.20  95.32  50,747 
03/24/2025 99.90  100.75  96.16  97.28  41,812 
03/21/2025 97.00  99.38  96.00  97.85  35,370 
03/20/2025 101.99  102.00  95.00  97.72  37,326 
03/19/2025 95.45  98.88  95.00  98.62  27,738 
03/18/2025 94.81  94.81  94.81  94.81  17,326 
03/17/2025 97.74  99.50  94.01  94.81  16,330 
03/13/2025 96.05  102.70  96.05  97.74  28,707 
03/12/2025 101.20  101.21  97.00  98.84  31,703 
03/11/2025 99.69  103.79  96.75  101.21  45,789 
03/10/2025 107.39  107.57  98.00  99.76  42,718 
03/07/2025 97.98  102.45  97.50  102.45  24,167 
03/06/2025 94.99  99.49  91.00  97.58  29,501 
03/05/2025 89.70  98.00  89.70  95.64  54,437 
03/04/2025 94.43  94.43  94.43  94.43  17,109 
03/03/2025 99.40  99.40  99.40  99.40  6,355 
02/28/2025 104.64  104.64  104.64  104.64  6,563 
02/27/2025 110.15  112.00  110.15  110.15  18,035 
02/25/2025 119.10  120.50  115.79  115.95  28,368 
02/24/2025 124.40  124.40  119.00  121.89  12,148 
02/21/2025 121.63  134.44  121.63  124.24  91,930 
02/20/2025 128.04  128.04  128.04  128.04  21,404 
02/19/2025 134.78  134.78  134.78  134.78  14,764 
02/18/2025 141.88  141.88  141.88  141.88  7,193 
02/17/2025 149.35  149.35  149.35  149.35  5,853 
02/14/2025 168.24  168.24  156.69  157.22  19,525 
02/13/2025 168.69  168.69  163.00  164.94  10,071 
02/12/2025 173.62  173.62  164.93  167.32  16,254 
02/11/2025 182.00  182.00  173.07  173.62  16,264 
02/10/2025 190.24  190.24  181.00  182.17  10,120 
02/07/2025 188.80  194.99  187.00  190.24  6,029 
02/06/2025 192.00  193.90  189.20  189.99  11,763 
02/05/2025 198.00  203.25  191.35  191.99  40,973 
02/04/2025 200.43  200.45  193.00  193.58  9,364 
02/03/2025 191.77  201.49  190.50  200.43  30,365 
01/31/2025 185.41  194.68  185.41  193.52  48,676 
01/30/2025 192.35  193.00  184.81  185.41  85,707 
01/29/2025 191.40  197.90  191.40  192.30  107,612 
01/28/2025 186.49  206.12  186.49  201.48  50,295 
01/27/2025 197.40  200.00  192.91  196.31  22,601 
01/24/2025 201.02  204.00  197.25  203.07  33,922 
01/23/2025 194.00  201.00  193.00  200.02  23,524 
01/22/2025 194.00  200.01  194.00  196.34  53,415 
01/21/2025 190.00  197.93  190.00  197.09  46,144 
01/20/2025 192.90  195.65  191.05  194.93  16,633 
01/17/2025 191.50  194.90  188.10  192.26  17,395 
01/16/2025 188.65  193.95  188.65  190.39  16,875 
01/15/2025 193.90  193.90  185.61  187.57  51,523 
01/14/2025 181.50  195.20  181.50  190.24  45,523 
01/13/2025 196.00  197.45  180.50  182.70  80,721 
01/10/2025 209.50  209.50  196.41  198.52  51,704 
01/09/2025 200.50  208.90  200.50  204.40  119,176 
01/08/2025 211.83  211.83  201.69  203.75  42,595 
01/07/2025 206.50  208.05  201.02  206.03  46,085 
01/06/2025 214.00  214.86  197.24  202.09  85,045 
01/03/2025 220.00  220.00  212.82  213.77  42,785 
01/02/2025 212.00  219.95  207.30  217.99  208,448 
12/31/2024 203.00  203.05  196.05  198.90  52,975 
12/30/2024 201.60  204.20  200.00  202.25  62,846 

About Par Drugs Stock history

Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.2 M11.2 M
Net Income Applicable To Common Shares106 M65.2 M

Par Drugs Quarterly Net Working Capital

337.1 Million

Par Drugs Stock Technical Analysis

Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Par Drugs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Par Drugs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

Par Drugs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Par Stock analysis

When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Transaction History
View history of all your transactions and understand their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.